Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02066974
What this trial is testing

Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy

Who this might be right for
Circulating Neoplastic CellsAdverse Effect of Radiation TherapyFatal Outcome
China Medical University, China 45
Testing effectiveness (Phase 2)UnknownNCT02242786
What this trial is testing

Diffusion-Weighted Magnetic Resonance Imaging

Who this might be right for
Hepatocellular CarcinomaSpine Metastasis
Samsung Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT03937830
What this trial is testing

Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma

Who this might be right for
Hepatocellular CancerHepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00055692
What this trial is testing

Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)WithdrawnNCT04025567
What this trial is testing

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Who this might be right for
Metastatic Hepatocellular CarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)
Not applicableStudy completedNCT05111795
What this trial is testing

Holmium-166 Retrospective Collection of Real-World Data

Who this might be right for
Hepatocellular CarcinomaMetastatic Cancer
Terumo Europe N.V. 146
Testing effectiveness (Phase 2)UnknownNCT01567930
What this trial is testing

Temsirolimus as Second-line Therapy in HCC

Who this might be right for
Unresectable or Metastatic Hepatocellular Carcinoma
University of Tennessee Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT03893695
What this trial is testing

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

Who this might be right for
Metastatic Hepatocellular CarcinomaHCCCombinations of Drugs; Dependence
Suzhou Kintor Pharmaceutical Inc, 20
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Post-approval studies (Phase 4)WithdrawnNCT03215355
What this trial is testing

Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer
Slawa Cwajna
Early research (Phase 1)Temporarily pausedNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Testing effectiveness (Phase 2)Ended earlyNCT00019604
What this trial is testing

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 44
Not applicableStudy completedNCT01411579
What this trial is testing

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Who this might be right for
Liver MetastasesHepatocarcinoma
Stefano Colagrande 57
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Testing effectiveness (Phase 2)Study completedNCT03439891
What this trial is testing

Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v7+4 more
Robin Kate Kelley 16
Not applicableStudy completedNCT02727673
What this trial is testing

Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Who this might be right for
Cancer Stem CellsPostoperative Recurrence and MetastasisHepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 1,000
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Next Page